Carrier-as-Prodrug Glycyrrhizic Acid Nanogel Co-Delivers Mannose and Glycyrrhetinic Acid for Metabolic-Ionic Cancer Therapy.

Sun B, Jin Z, Yishan AS, Liang B, Zou C, Wang C, Qi Y, Xia Y, Cui D, Shen Y, Guo S

Open source

DOI
10.1021/acsami.6c10812
Published
2026 Sep 2
Container
ACS applied materials & interfaces
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsami.6c10812,
  title = {Carrier-as-Prodrug Glycyrrhizic Acid Nanogel Co-Delivers Mannose and Glycyrrhetinic Acid for Metabolic-Ionic Cancer Therapy.},
  author = {Sun B and Jin Z and Yishan AS and Liang B and Zou C and Wang C and Qi Y and Xia Y and Cui D and Shen Y and Guo S},
  year = {2026},
  journal = {ACS applied materials \& interfaces},
  doi = {10.1021/acsami.6c10812},
  url = {https://doi.org/10.1021/acsami.6c10812}
}

RIS

TY  - JOUR
TI  - Carrier-as-Prodrug Glycyrrhizic Acid Nanogel Co-Delivers Mannose and Glycyrrhetinic Acid for Metabolic-Ionic Cancer Therapy.
AU  - Sun B
AU  - Jin Z
AU  - Yishan AS
AU  - Liang B
AU  - Zou C
AU  - Wang C
AU  - Qi Y
AU  - Xia Y
AU  - Cui D
AU  - Shen Y
AU  - Guo S
PY  - 2026
JO  - ACS applied materials & interfaces
DO  - 10.1021/acsami.6c10812
UR  - https://doi.org/10.1021/acsami.6c10812
ER  - 

APA

B, S., Z, J., AS, Y., B, L., C, Z., C, W., Y, Q., Y, X., D, C., Y, S., & S, G. (2026). Carrier-as-Prodrug Glycyrrhizic Acid Nanogel Co-Delivers Mannose and Glycyrrhetinic Acid for Metabolic-Ionic Cancer Therapy.. ACS applied materials & interfaces. https://doi.org/10.1021/acsami.6c10812

Source records